The CYP2C192 and CYP2C1917 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. [electronic resource]

By:

Saydam, Faruk

Contributor(s):

Değirmenci, İrfan
Birdane, Alparslan
Özdemir, Mahmut
Ulus, Taner
Özbayer, Cansu
Çolak, Ertuğrul
Ata, Necmi
Güneş, Hasan Veysi

Producer: 20180403Description: 29-36 p. digitalISSN:

1742-7843

Subject(s):

Aged
Aspirin -- pharmacology
Clopidogrel
Coronary Artery Disease -- surgery
Cytochrome P-450 CYP2C19 -- genetics
Female
Gene Frequency
Genotype
Humans
Male
Middle Aged
Myocardial Ischemia -- etiology
Percutaneous Coronary Intervention -- adverse effects
Platelet Activation -- drug effects
Platelet Aggregation -- drug effects
Platelet Aggregation Inhibitors -- pharmacology
Polymorphism, Single Nucleotide
Postoperative Complications -- etiology
Sequence Analysis, DNA
Stents -- adverse effects
Thrombosis -- etiology
Ticlopidine -- analogs & derivatives
Treatment Outcome
Turkey

Online resources:

Available from publisher's website

In: Basic & clinical pharmacology & toxicology vol. 121

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

The CYP2C192 and CYP2C1917 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

APA

Saydam F., Değirmenci İ., Birdane A., Özdemir M., Ulus T., Özbayer C., Çolak E., Ata N. & Güneş H. V. (20180403). The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. : Basic & clinical pharmacology & toxicology.

Chicago

Saydam Faruk, Değirmenci İrfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertuğrul, Ata Necmi and Güneş Hasan Veysi. 20180403. The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. : Basic & clinical pharmacology & toxicology.

Harvard

Saydam F., Değirmenci İ., Birdane A., Özdemir M., Ulus T., Özbayer C., Çolak E., Ata N. and Güneş H. V. (20180403). The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. : Basic & clinical pharmacology & toxicology.

MLA

Saydam Faruk, Değirmenci İrfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertuğrul, Ata Necmi and Güneş Hasan Veysi. The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. : Basic & clinical pharmacology & toxicology. 20180403.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC

The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. [electronic resource]

The CYP2C192 and CYP2C1917 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. [electronic resource]